Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Cellectar Biosciences, Inc. Director's Dealing 2016

Nov 2, 2016

35021_dirs_2016-11-01_1e4bab72-3a40-435e-b6ee-8a2c40519938.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cellectar Biosciences, Inc. (clrB)
CIK: 0001279704
Period of Report: 2016-08-09

Reporting Person: Hertzberg Richard (significant owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-10-31 Cellectar Biosciences, Inc. common stock (CLRB) S 21000 $2.029 Disposed 280000 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2016-08-09 Cellectar Biosciences Inc. Warrant (CLRBW) $46.8 S 40916 Disposed 2019-08-20 Cellectar Biosciences, Inc. common stock (CLRB) (40916) Direct

Footnotes

F1: CLRB stock sales during period October 13 through October 31, 2016

F2: Price of CLRB at close of market 11/1/2016